News tagged ‘BreastCancer’ clear
- In an editorial in the New England Journal of Medicine, Dr. Javid Moslehi commented on the need for assessing cardiac risk factors for breast cancer patients starting radiation. (Full article requires a subscription)
Tags: BreastCancer, Radiation
- A new study shows the number of mastectomies is on the rise. Dr. Mehra Golshan explains one reason why is that women are worried about the cancer coming back in the breast or occurring in the opposite one.
- A recent study found that for every 2,500 women offered mammograms over ten years, one breast-cancer death was averted, but six to ten women were subjected to unnecessary surgery, radiation and/or chemotherapy. Dr. Eric Winer of Dana-Farber said that while there are patients who are overtreated, there also are 40,000 women every year who die of breast cancer. (Full article requires a subscription)
- A study led by Dr. Richard Gelber found that treating HER-2 positive breast cancer for one year with trastuzumab remains the standard of care. Researchers compared outcomes of the standard one-year course to a two-year treatment and a six-month treatment, and determined the one-year course was most beneficial.
- Dana-Farber patient Tara Shuman of Canton, who was diagnosed with breast cancer in August 2012, chronicles her journey and shares how she gained perspective and awareness during her battle with the disease.
- Children diagnosed with cancer remain at risk from a variety of serious, long-term complications. Dr. Lisa Diller from Dana-Farber/Children's Hospital Cancer Center says that new treatments can mitigate these risks for the next generation of pediatric cancer survivors.
Tags: BreastCancer, ChildhoodCancer, Survivorship
- Dana-Farber researchers, including Dr. Kornelia Polyak, have developed a mathematical model to predict how a patient’s tumor is likely to behave and which of several possible treatments is most likely to be effective.
Tags: BreastCancer, Genomics
Showing 11-20 of 67 items